A predictive and mechanistic model was used for comparison with published values of tumor and endocrine pancreas uptake for two classes of targeting molecules (Fig. 3) – HER2 binding affibodies (MW ~ 6 kDa) and GLP-1R binding peptides (MW ~ 5 kDa for monomer). This evidence concerns the gene ERBB2 and neoplasm.